April 16, 2021
Article
April 12, 2021
A study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
A recent study finds increasing number of women with PsA, but an overall stable incidence of disease compared to previous studies in same population.
April 07, 2021
Patients with psoriasis who either remained on Humira or switched to a biosimilar showed similar retention rates and efficacy/safety data.
March 27, 2021
A meta-analysis notes that relative risk for stroke was high for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and gout.
March 17, 2021
A majority of patients with active psoriatic arthritis achieved and maintained skin clearance, joint symptom relief through year 2 of treatment.
February 17, 2021
Apremilast has been prescribed to more than 250,000 patients with plaque psoriasis or psoriatic arthritis since it was approved in 2014.
January 05, 2021
The IL-23 inhibitor is shown to improve disease activity across joint and skin symptoms.
December 04, 2020
It is feasible to discontinue methotrexate in patients who had received tofacitinib combination therapy.
December 03, 2020
Video
